MetaCap

Bullfrog AI (BFRG) vs Ensysce Biosciences (ENSC)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Ensysce Biosciences is the larger company by market cap ($7.0 million vs $6.6 million), about 1.1 times the size. Ensysce Biosciences converts more of its revenue into profit, with a net margin of -200.8% versus -5569.6%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BFRG-49.82%ENSC-16.16%
+44%-5%-54%
Oct 7, 20261 yearNov 20, 2026
BFRG-44.95%ENSC-31.69%
+2%-22%-47%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BFRG versus ENSC key metrics
MetricBFRGENSC
Share price$0.3556$0.36
Market cap$6.65M$7.00M
1-day change-8.84%-0.17%
YTD return-59.73%—
1-year return-58.21%—
EPS (TTM)$-0.41$-7.51
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$116.67K$5.07M
Revenue growth (YoY)—-2.75%
Net income (latest FY)$-6.50M$-10.18M
Gross margin18.76%—
Operating margin-5652.38%-202.12%
Net margin-5569.61%-200.85%
52-week high$1.96$1.85
52-week low$0.35$0.23
Distance from 52-week high-81.86%-80.54%
Analyst consensusnonenone
Avg. price target upside—+2191.67%
Average volume5.38M493.43K
Shares outstanding18.69M19.46M
Employees98
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Ensysce Biosciences is more profitable, keeping -200.8 cents of every revenue dollar as net income versus -5569.6 cents for Bullfrog AI.

About Bullfrog AI

BFRG stock →

Bullfrog AI Holdings, Inc. operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States.

Health Care · Biotechnology: Pharmaceutical Preparations · 9 employees

About Ensysce Biosciences

ENSC stock →

Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection (TAAP) platform, designed to release clinically effective drugs only when exposed to specific physiological conditions; and Multi-Pill Abuse Resistance (MPAR) platform, an over-dose protection opioid prodrug technology.

Health Care · Biotechnology: Pharmaceutical Preparations · 8 employees

BFRG vs ENSC FAQ

Which is bigger, Bullfrog AI or Ensysce Biosciences?

Ensysce Biosciences (ENSC) is larger, with a market capitalization of $7.00M compared with $6.65M for Bullfrog AI (BFRG).

Are Bullfrog AI and Ensysce Biosciences in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons